BERRY GENOMICS(SZ:000710)2022-12-07 08:58Group 1: Company Restructuring and Debt Situation - The company has temporarily withdrawn its major asset restructuring application due to unresolved issues regarding the freezing of shares held by the controlling shareholder [2] - As of May 27, 2015, the China Securities Regulatory Commission issued a notice to terminate the review of the company's administrative license application [2] - The controlling shareholder holds 88.96 million shares, of which 79.02 million shares are currently frozen due to a financial loan dispute involving approximately 278 million yuan, nearing 300 million yuan with interest [2] Group 2: Business Operations and Future Prospects - Despite poor operational performance, the company maintains a clean financial record without external guarantees or contingent liabilities, primarily relying on bank loans [2] - If relocation compensation funds are fully in place, the company's financial pressure will ease, leading to a reduction in debt [3] - The company is exploring potential cooperation with other firms if the share freezing issue remains unresolved in the short term [3] - The automotive instrument industry is facing significant challenges, while the medical equipment sector shows higher profit margins and promising prospects [3] - The timeline for restructuring outcomes remains uncertain, dependent on the resolution of the share freezing issue and the willingness of potential partners to wait [3]